With reference to the earlier intimation dated April 05, 2018 of next Board meeting, Biocon has now informed about consideration and recommendation of final dividend, if any, for the financial year 2017-18 forms part of the agenda of the meeting of Board of Directors of the company, scheduled on April 26, 2018.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1837.40 |
| Dr. Reddys Lab | 1306.00 |
| Cipla | 1371.30 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2456.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: